|
|
Position:
Research Associate III
Employer:
Nektar Therapeutics
Description:
The successful candidate will be responsible for developing and performing Ligand Binding Assays (e.g. ELISAs, ECLAs) for pharmacokinetic (PK), toxicokinetic (TK) and anti-drug antibodies (ADAs) assessments to advance research, pre-clinical, and clinical stage programs. The successful candidate will also be responsible for performing routine tasks as directed to maintain the laboratory.
Essential/Primary Duties, Functions and Responsibilities
- Analyze clinical samples in compliance with GCP/GLP regulations and Nektar’s SOPs.
- With guidance, develop complex assays for measuring the PK/TK of Nektar’s PEGylated-protein, drug candidates.
- Compile data and analyze results in terms of quality/validity.
- Document all activities in the electronic notebook and Laboratory Information Management System (LIMS).
- Perform routine equipment maintenance, calibrations, and verifications as per SOP.
- Collaborate with other bioanalytical team members to complete tasks and meet departmental goals.
- Collaborate with members of other departments to complete tasks when required.
- Prepare study reports and SOP revisions.
Qualifications/Experience:
A minimum of a Bachelor’s degree in biology, biochemistry, or other related scientific discipline with 5+ years of work experience. Equivalent experience may be accepted. In depth technical knowledge to understand the caveats of Ligand Binding Assays and to recognize issues during development and sample analysis. Experience performing and developing Ligand Binding Assays for PK/TK. Experience working in a GCP/GLP environment is desirable. Ability to work on multiple task/projects at the same time. Ability to work in a fast-paced, goal-oriented environment. Effective time-management skills.
Self-motivated to carry out both new and routine tasks. Detailed oriented and able to follow instructions. Must be willing to work as part of a team and demonstrate good interpersonal skills. Proficient working with Microsoft Word, Excel, and PowerPoint. Past experience with electronic notebook systems and or LIMS a plus.
Location:
San Francisco (Mission Bay)
Contact:
acandia@nektar.com
Post Date:
10/3/2019 9:00:41 AM
|
|
Ads (in random order)
Submit a Text Ad ($250 for 2 months)
Hypha Discovery
Synthesis, purification & NMR characterization of phase I and II drug metabolites & API impurities at mg-g scale with COAs.
|
Alturas Analytics, Inc.
Expert Regulated & Non-Regulated LC-MS, GC-MS bioanalytical & PK/TK analysis of small & large molecules in any matrix. Discovery through phase IV.
|
Lena Biosciences
Predictive toxicology. Mitochondrial toxicity in a drug metabolism-competent model with active transporters. Intrinsic & idiosyncratic DILI.
|
Lena Biosciences
Predictive toxicology. Intrinsic & idiosyncratic drug-induced liver injury. Mitochondrial toxicity in a drug metabolism-competent model.
|
Submit a Text Ad
|